Megola, INC / Acordy Sa (OTCBB:MGON) Provides Shareholder Update with Expansion of Cannabis Products to US Markets
Houston, Texas, Oct. 25, 2018 (GLOBE NEWSWIRE) — Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to announce expansion of its products and sales distributions into the United States and Canadian cannabis markets. Acordy President Francisco Baez states: “Megola plans on introducing medical marijuana products into the U.S. developed by it’s affiliated company Acordy S.A. based in Malaga, Spain. Megola is also in advanced negotiations with a U.S. developer of new, innovative and therapeutic medical marijuana products”. Eric Ottens, CEO of Megola states, “We are leveraging the already existing product set of Acordy to quickly launch, produce and sell into the US and Canadian cannabis markets.”
Francisco Baez also stated, “We have secured legal counsel and we are taking the necessary steps to bring all OTC filings current. While we are currently trading on the Pinksheets, we plan on moving up to OTCQB or OTCQX within the next 6-12 months..”
The company also wishes to notify all shareholders and persons of interest that Megola, Inc. will be making announcements and updates via social media media. Updates can be found at on newly created new social media channels on Twitter https://twitter.com/MegolaMMJ and a Facebook Business Page https://www.facebook.com/Megola-Inc-1844493719004617 .
Management also wants to notify all shareholders and persons of interest to visit http://www.acordyinvest.com for updates and notifications of the company’s original programs and directives.
About Acordy SA.
Acordy S.A. is currently a privately owned Spanish company that was formed in 2014. Acordy has been primarily involved in the production and distribution of food items from Spain with a concentration in olive oils and wines from the Iberian Peninsula. Acordy is also involved with commercial horse breeding. The company is currently planning to become involved in the production and distribution of medical marijuana products and already has the necessary infrastructure in place to commence commercializing CBD products in the next three months.
Sections of this press release contain forward looking statements that reflect management’s best judgement based on factors currently known but involve significant risks and uncertainties. Actual results could differ materially from those anticipated in these forward looking statements as a result of a number of factors that will be included in the forthcoming financial statements. Forward looking information provided pursuant to the safe harbor established by recent securities legislation should be evaluated in the context of these factors.
SOURCE Megola, Inc.